Enjoy complimentary customisation on priority with our Enterprise License!
Below are some of the key findings from the prostate cancer testing market research report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Get a FREE sample now!
The increasing incidences of prostate cancer is one of the primary factors that will trigger the growth of the prostate cancer testing market in the coming years. The incidence of prostate cancer is increasing worldwide and is the second most common cancer diagnosed in men. It is estimated that every year approximately one million new cases of prostate cancer are diagnosed worldwide. Over the last few decades, the incidence rate of prostate cancer has increased owing to the rising older population, growing urbanization, and associated lifestyle changes. This will further lead the prostate cancer testing market to grow at a CAGR of close to 11% by 2022.
The increasing focus on biomarker research is one of the key trends in the prostate cancer testing market. The development of biomarkers has accelerated with the recent developments in high throughput technology platforms in proteomics, genomics, and immunology. The manufacturers are focusing on developing prostate cancer biomarkers which can foretell disease aggressiveness and drive better treatment decisions.
The prostate cancer testing market is moderately fragmented with companies focusing on increasing R&D and investments in the development of innovative products. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this prostate cancer testing industry analysis report will aid clients to form effective business strategies for strengthening their position in the market.
The report offers a complete analysis of various companies including:
With a complete study of the growth opportunities for the companies, the Americas will account for the highest prostate cancer testing share throughout the forecast period. However, the APAC region is likely to contribute the highest incremental growth during the forecast period primarily due to the presence of a huge patient pool and the growing awareness about prostate cancer.
The biomarkers segment will account for the highest growth in the market primarily supported by the increasing awareness about the clinical benefits of advanced biomarkers. Additionally, the report also provides an accurate prediction of the contribution of the various products segments impacting the growth of the prostate cancer testing market size.
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY PRODUCT
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.